These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27325614)

  • 41. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis.
    Elst J; De Puysseleyr LP; Ebo DG; Faber MA; Van Gasse AL; van der Poorten MM; Decuyper II; Bridts CH; Mertens C; Van Houdt M; Hagendorens MM; De Clerck LS; Verlinden A; Vermeulen K; Maes MB; Berneman ZN; Valent P; Sabato V
    Front Immunol; 2022; 13():835618. PubMed ID: 35281031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
    Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
    Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.
    Valent P; Akin C
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of international consensus equation for acute serum total tryptase in mast cell activation: A perioperative perspective.
    Baretto RL; Beck S; Heslegrave J; Melchior C; Mohamed O; Ekbote A; Huissoon AP; Krishna MT
    Allergy; 2017 Dec; 72(12):2031-2034. PubMed ID: 28609557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendations for the Use of Tryptase in the Diagnosis of Anaphylaxis and Clonal Mastcell Disorders.
    Platzgummer S; Bizzaro N; Bilò MB; Pravettoni V; Cecchi L; Sargentini V; Caponi L; Visentini D; Brusca I; Pesce G; Bagnasco M; Antico A; Montera MC; Quercia O; Musarra A; Bonazza L; Borrelli P; Cortellini G; Polillo BR; Valenti B; Zedda MT; Asero R; Villalta D
    Eur Ann Allergy Clin Immunol; 2020 Mar; 52(2):51-61. PubMed ID: 31994369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis.
    Marcella S; Petraroli A; Canè L; Ferrara AL; Poto R; Parente R; Palestra F; Cristinziano L; Modestino L; Galdiero MR; Monti M; Marone G; Triggiani M; Varricchi G; Loffredo S
    Eur J Intern Med; 2023 Nov; 117():111-118. PubMed ID: 37500310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
    Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
    J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH; Ravi A; Pongdee T
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on idiopathic anaphylaxis.
    Calvani M
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27():52-53. PubMed ID: 35080312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
    Zaghmout T; Maclachlan L; Bedi N; Gülen T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effector cells of anaphylaxis: mast cells and basophils.
    Schwartz LB
    Novartis Found Symp; 2004; 257():65-74; discussion 74-9, 98-100, 276-85. PubMed ID: 15025392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy.
    Kinney SR; Carlson L; Ser-Dolansky J; Thompson C; Shah S; Gambrah A; Xing W; Schneider SS; Mathias CB
    PLoS One; 2015; 10(7):e0132467. PubMed ID: 26147007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum mast cell tryptase measurements: Sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia.
    Francis A; Fatovich DM; Arendts G; Macdonald SP; Bosio E; Nagree Y; Mitenko HM; Brown SG
    Emerg Med Australas; 2018 Jun; 30(3):366-374. PubMed ID: 29094472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.
    Bonadonna P; Pagani M; Aberer W; Bilò MB; Brockow K; Oude Elberink H; Garvey L; Mosbech H; Romano A; Zanotti R; Torres MJ
    Allergy; 2015 Jul; 70(7):755-63. PubMed ID: 25824492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
    Gülen T; Hägglund H; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.